12-NON Competitive CSS 75N98027Q00097.docx

DOCX document 88 KB Posted

Attached to
Liquid Nitrogen Gas (LN2) service for Clinical Biorepository Freezers
Solicitation number
75N98027Q00097
Issued by

About this file

This is a Combined Synopsis/Solicitation (RFQ) for Liquid Nitrogen Gas (LN2) service. The National Institutes of Health (NIH) National Cancer Institute (NCI) Surgery Branch Cell Production Facility requires weekly LN2 delivery and maintenance services for Clinical Biorepository Freezers located in Building T30, Room 101, at the NIH Bethesda campus (20892). The service supports the cGMP T30 Cell Production Facility's critical storage of patient samples and cell therapy manufacturing for immunotherapy clinical trials, with strict FDA and 21 CFR Part 210/211 compliance requirements. The estimated period of performance runs from December 2, 2026, through December 1, 2027. The contractor must deliver approximately 70 shipments annually, totaling 210 LN2 tanks per year, with tanks installed at the manifold in the cylinder room. The service includes tank delivery, setup, installation, certificates of batch analysis for each tank, on-site maintenance per manufacturer standards, and email notifications when approximately 21 tanks remain. Additional deliveries may be requested if usage increases or delays are anticipated due to weather or federal holidays.

This is a firm fixed price, unrestricted solicitation (NAICS code 325120, Industrial Gas Manufacturing) with no small business set-aside. Responses must be received by November 30, 2026, at 8:00 A.M. EST, with questions due by November 24, 2026. Offerors must submit capability statements or quotations demonstrating ability to perform, including unit pricing, shipping and handling costs, delivery timeframe, F.O.B. point, and product descriptions. All respondents must provide UEI, TIN, business size certification, and maintain active SAM.gov registration. Evaluation will be based on best value for offerors meeting minimum requirements, considering past performance, technical capability, warranty, maintenance availability, and other relevant factors. Award will be made to the responsible vendor whose quote represents the best value tradeoff. Responses should be submitted electronically to Francisca Wagstaff (wagstaff@nih.gov) with a copy to Luz Casey (Luz.Casey@nih.gov), referencing solicitation number 75N98027Q00097.

View the file

Other files

File Type Posted
05-UPDATED SOW-2026 T30 LN2_.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Hospital and Laboratory Support Division Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM)

Title: Liquid Nitrogen Gas (LN2) service for Clinical Biorepository Freezers

Combined Synopsis Solicitation

Synopsis No. 75N98027Q00026 Synopsis No. 75N98027Q00097

COMBINED SYNOPSIS / SOLICITATION WORKFORM

Type: Combined Synopsis/Solicitation
Posted Date: November 18, 2026
Subject/Title: Liquid Nitrogen Gas (LN2) service for Clinical Biorepository Freezers
Solicitation Number: 75N98027Q00097
Questions Due Date: November 24, 2026 at 8:00 A.M Eastern Standard Time (EST)
Closing Response Date: November 30, 2026 at 8:00 A.M. Eastern Standard Time (EST)
Contract Award Type: Firm Fixed Price
Contact Point(s): Francisca Wagstaff, Program Specialist, wagstaff@nih.gov

Contracting Office:

National Institutes of Health (NIH) Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division Contracting Office Address:

6701 Rockledge Drive Bethesda, MD 20817

Place of Contract Performance:

Bethesda, MD 20892

Set-aside Status: N/A
Brand Name or Equal Acquisition: N/A

This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued.

Solicitation number 75N98027Q00097 is issued as a request for quotation (RFQ) for the NCI Liquid Nitrogen Gas (LN2) service for Clinical Biorepository Freezers. This is intended to be a firm-fixed price contract.

The NAICS code is 325120, Industrial Gas Manufacturing. This acquisition is not set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. This solicitation is being released unrestricted.

Any available business or small businesses may submit capability statement, proposal, or quotation that clearly supports and demonstrates their ability to perform the requirement. A determination by the Government to compete this proposed award is solely within the discretion of the Government. The Government will make award to the responsible vendor whose quote represents best value tradeoff for Offerors who meet minimum requirements. The Government may select a higher-priced quote if it is determined that the additional technical merit or lower performance risk warrants the price premium. The solicitation document, the incorporated provisions, and clauses are those in effect through Federal Acquisition Circular 2024-07, effective August 29, 2024.

Description of Requirement:

The National Institutes of Health (NIH) / National Cancer Institute (NCI) / NCI Surgery Branch Cell Production Facility requires Liquid Nitrogen Gas (LN2) services for Clinical Biorepository Freezers for the NCI Surgery Branch cGMP T30 Cell Production Facility.

This year long service contract (depended on usage) is for a weekly stop and check, for NF grade LN2 delivery service to be rendered to the cylinder room 101 of the T30 NCI SB current Good Manufacturing Practices (cGMP) Cell Production Facility on the NIH Bethesda campus by a vendor qualified by the NCI SB Quality Assurance group overseeing the cGMP compliance in accordance with the 21CFR part 210/211 and FDA regulations.

The LN2 tanks are used to maintain the cellular biorepository cryofreezer which is a critical component to the storage of patient samples and patient cell therapy manufacturing. These freezers house the starting cells that are grown and modified to be infused into patients as a part of the immunotherapy clinical trials at NCI Surgery Branch as well as the site for the FDA mandated storage of retention samples. Disruption to the supply and availability of LN2 to support the freezers at the correct temperature prevent the production of patient therapies, the ability to conduct the follow up research or any necessary investigations as well as a failure to meet CFR and FDA requirements. Continuous monitoring on the levels of LN2 is critical to the patient therapy manufacturing process.

The estimated Period of Performance will be December 2, 2026 - December 1, 2027.

Requirements:

The Contractor shall provide all labor, material and equipment necessary for the current rate of usage consisting of 70 deliveries of three (3) LN2 gas tanks per delivery, for a total of 210 tanks per year. The service for each delivery will include tank delivery to the gas cylinder room, set up, and installation of the required number of LN2 tanks at the manifold.

Additional tanks per delivery or an additional delivery within the same week may be requested if the rate of usage by the cryofreezers indicates a need or if there is an anticipated delay until the next delivery that is expected to impact available levels of LN2 to the cryofreezers (i.e. inclement weather, federal holidays).

The lowest filled tanks (30% and less) will be replaced with the delivered tanks. All tanks will be properly installed in the pre-existing sequence to ensure the manifold can pull from all tanks as they deplete. In addition to delivery and installation, certificates of batch analysis shall be provided for each tank.

All maintenance services shall be performed on-site in accordance with the manufacturer’s standard commercial maintenance practices. The Contractor shall notify the Point of Contact directly when ~21 tanks are remaining. Notification shall occur via email with a summary of to date total usage and remaining tanks/service.

Delivery Location:

NIH, NCI Surgery Branch Cell Production Facility (CPF/TIL Lab) Building T30 T30 Convent Drive. Room 101 Bethesda, MD 20892

The following Terms and Conditions apply:

· FAR 52.204-7, System for Award Management, applies to this acquisition.

· The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any additional instructions as required.

· The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

· A written notice of award or acceptance of an offer, issued to the successful offeror within the time specified in the offer, shall result in a binding contract without further action by either party.

· The Government reserves the right to accept any offer (or part of an offer) before the expiration date, whether or not discussions are conducted, unless a written notice of withdrawal is received prior to award. Add additional evaluation criteria as required.

· FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

· Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices: None.

· The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.

Submission Requirements:

Responses must include sufficient information to demonstrate the respondent’s capability to provide the required product or service. Price quotations shall include, at a minimum: unit price, list price, shipping and handling costs, delivery timeframe after award, delivery terms, prompt payment discount terms, F.O.B. point (destination or origin), product or catalog numbers, product descriptions, and any other relevant information.

Evaluation factors may include, but are not limited to: past performance, technical capability, special features, trade-in considerations, expected lifecycle, warranty, maintenance availability, and environmental or energy efficiency considerations.

Respondents claiming to be manufacturers or authorized resellers of a specified brand-name product must provide:

(a) Product, catalog, model, and/or part number(s);

(b) Product description;

(c) Documentation demonstrating that the offered item meets all required salient characteristics;

(d) Quantity;

(e) Estimated price or cost;

(f) Shipping, handling, and/or installation charges; and

(g) Delivery timeframe after receipt of order.

Evaluation Criteria:

The Government will award a contract resulting from this requirement based on best value for Offerors who meet minimum requirements. Offerors who do not demonstrate the ability to meet these minimum requirements will not be considered.

Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

Questions must be in writing and are due by Tuesday, November 24, 2026 at 8:00 A.M. EST. All responses must be received by November 30, 2026 at 8:00 A.M. EST and must reference solicitation number 75N98027Q00097.

Responses may be submitted electronically to Francisca Wagstaff at wagstaff@nih.gov, and copy Luz Casey at Luz.Casey@nih.gov.

2 | Page image1.png

File details come from the government source that posted it. Updated .